Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 24 May 1996:
Vol. 272. no. 5265, pp. 1094 - 0
DOI:

Prev | Table of Contents | Next

News & Comment

Eliot Marshall

Jeremy Rifkin, the author-activist who's never met an engineered gene he liked, kicked off a new campaign against the use of human genetic data on 21 May in Washington, D.C. With endorsements from members of women's health movements in 69 nations, he unveiled a campaign that will attack the patenting of breast cancer genes BRCA1 and BRCA2 and push for new laws to limit access to human genetic data in research, medicine, and commerce. But like other coalitions he has put together in the past to oppose genetic engineering, the members of this coalition may have different agendas.




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)